Development of the use of tumour necrosis factor related apoptosis inducing ligand or apo2 ligand (trail) as an efficient anti-tumour therapy as an alternative to chemo/radiotherapy.
Design and target-oriented synthesis of various novel estrogen receptor modulators. Assessment of their pharmacological abilities to act as estrogens in the skeletal and cardiovascular systems and antiestrogens against breast cancer.
Development and validation of a prediction algorithm for rationalisation of the dosing strategies for higher risk drugs
To develop a novel formulation of naturally occurring anti-oxidant/ anti-inflammatory compounds for the management and adjunctive therapy of inflammatory bowel disease (ibd).
To develop a multi-test platform to guarantee the milk quality (composition) of mediterranean milk mixture cheeses.